Erwin Coesemans
14Patents
3h-index
39Co-inventors
60Inventor score
Filing activity: Feb 14, 2002 → Jun 16, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6911444B2 | Non-steroidal IL-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors | Chemistry; Metallurgy | 10 | Expired |
| US7232838B2 | 2-amino-4,5-trisubstituted thiazolyl derivatives | Chemistry; Metallurgy | 7 | Expired |
| US7511068B2 | Mercaptoimidazoles as CCR2 receptor antagonists | Chemistry; Metallurgy | 4 | Expired |
| US8981094B2 | Piperidine/piperazine derivatives | Chemistry; Metallurgy | 1 | Active |
| US8633197B2 | Piperidine/piperazine derivatives | Chemistry; Metallurgy | 1 | Active |
| US11083707B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US8946228B2 | Piperidine/piperazine derivatives | Chemistry; Metallurgy | 0 | Active |
| US11053196B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US7803823B2 | 2-amino-4,5-trisubstituted thiazolyl derivatives | Chemistry; Metallurgy | 0 | Active |
| US11795149B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US11702387B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US11407715B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US9227935B2 | Piperidine/piperazine derivatives | Chemistry; Metallurgy | 0 | Active |
| US11491148B2 | Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.